EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Defining the tumor microenvironment of non‐small cell lung cancer

Kidane Siele Embaye, Tony Blick, Vahid Yaghoubi Naei, Ken O'Byrne, Brett G M Hughes, Arutha Kulasinghe iD

Immunology & Cell Biology · 2026-05 · 104 (5) · 499-518

DOI: 10.1111/imcb.70114 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology & Cell Biology, online erschienen am 10.04.2026. Verfasst von Kidane Siele Embaye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD, Australia. Hauptthemen laut MEDLINE: Tumor Microenvironment, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Future Fund, PA Research Foundation, Cure Cancer Australia Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is the most frequent cause of cancer‐related mortality globally. In recent years, the treatment landscape for advanced‐stage non‐small‐cell lung cancer (NSCLC) has been transformed by the advent of immunotherapy, which has yielded unprecedented and durable clinical responses for some patients. This shift has powered a significant expansion of novel immunotherapeutic strategies in oncology over the past few decades, heralding a new direction in the management of NSCLC. Despite these advances, only a fraction of patients acquire sustained benefit from immunotherapy, while the majority often develop resistance, resulting in disease progression leading to death. Several factors may contribute to this limited success, notably tumor heterogeneity and the intricate composition of the tumor microenvironment (TME). As a result, it is imperative to fully dissect the heterogeneity of the TME by identifying the principal drivers of cancer progression and immunotherapy resistance. This understanding is crucial for optimizing individualized treatment approaches. Here, we provide a summary of NSCLC, discuss the cardinal features of the TME and review advanced technologies such as spatial profiling of tissues, which are useful in dissecting the dynamicity of the tumor ecosystem. In addition, we highlight the recent developments and future perspectives of immunotherapy and other emerging therapeutics, as well as the role of predictive biomarker testing to ensure tailored therapy and tackle drug resistance, on the pathway to precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentCarcinoma, Non-Small-Cell LungLung NeoplasmsHumansAnimalsImmunotherapy

Stichwörter der Autor:innen

NSCLCimmunotherapylung cancertumor microenvironment

Autor:innen und Institutionen

  • Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD, Australia.
  • School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia.
  • The Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • The Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
  • Health, Medicine and Behavioural Sciences, University of Queensland, Brisbane, QLD, Australia.
  • Queensland Spatial Biology Centre, Wesley Research Institute, The Wesley Hospital, Brisbane, QLD, Australia.

ORCID-Profile: Arutha Kulasinghe

Förderung

  • Medical Research Future Fund
  • PA Research Foundation
  • Cure Cancer Australia Foundation

Zitieren

APA

Embaye, K. S., Blick, T., Naei, V. Y., O'Byrne, K., Hughes, B. G. M., & Kulasinghe, A. (2026). Defining the tumor microenvironment of non‐small cell lung cancer. Immunology & Cell Biology, 104(5), 499-518. https://doi.org/10.1111/imcb.70114

Vancouver

Embaye KS, Blick T, Naei VY, O'Byrne K, Hughes BGM, Kulasinghe A. Defining the tumor microenvironment of non‐small cell lung cancer. Immunology & Cell Biology. 2026;104(5):499-518. doi:10.1111/imcb.70114

BibTeX
@article{Embaye2026,
  author = {Embaye, Kidane Siele and Blick, Tony and Naei, Vahid Yaghoubi and O'Byrne, Ken and Hughes, Brett G M and Kulasinghe, Arutha},
  title = {Defining the tumor microenvironment of non‐small cell lung cancer},
  journal = {Immunology & Cell Biology},
  year = {2026},
  volume = {104},
  number = {5},
  pages = {499--518},
  doi = {10.1111/imcb.70114}
}
Kostenlos starten →